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Abstract: Identification of the fetus at risk of adverse outcome at term 
is a challenge to both clinicians and researchers alike. Despite the fact 
that fetal growth restriction (FGR) is a known risk factor for 
stillbirth, at least two thirds of the stillbirth cases at term are not 
small for gestational age (SGA) - a commonly used proxy for FGR.  
However, the majority of SGA fetuses are constitutionally small babies 
and do not suffer from adverse perinatal outcome. Doppler 
cerebroplacental ratio (CPR) is emerging as a marker of failure to reach 
growth potential at term. CPR is an independent predictor of intrapartum 
fetal distress, admission to the neonatal unit at term, stillbirth, 
perinatal death and neonatal morbidity. Raised uterine artery Doppler 
resistance in the third trimester is independently associated with 
significantly lower birthweight and CPR. The combination of the estimated 
fetal weight, CPR and uterine Doppler in the third trimester can identify 
the majority of fetuses at risk of stillbirth. 
 
 
 
 
HIGHLIGHTS 
 Despite the fact that fetal growth restriction (FGR) is a known risk factor for stillbirth, the 
majority of fetuses suffering from stillbirth at term are not small for gestational age.  
 Serial measurements to assess growth velocity, combined with fetal Doppler, are 
preferable than a single point estimate. 
 The cerebroplacental ratio (CPR) is emerging as a marker of failure to reach growth 
potential at term 
 The combination of the estimated fetal weight, CPR and uterine Doppler in the third 
trimester can identify the majority of fetuses at risk of stillbirth 
 
Highlights (for review)
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ABSTRACT 
 
Identification of the fetus at risk of adverse outcome at term is a challenge to both clinicians 
and researchers alike. Despite the fact that fetal growth restriction (FGR) is a known risk 
factor for stillbirth, at least two thirds of the stillbirth cases at term are not small for gestational 
age (SGA) - a commonly used proxy for FGR.  However, the majority of SGA fetuses are 
constitutionally small babies and do not suffer from adverse perinatal outcome. Doppler 
cerebroplacental ratio (CPR) is emerging as a marker of failure to reach growth potential at 
term. CPR is an independent predictor of intrapartum fetal distress, admission to the 
neonatal unit at term, stillbirth, perinatal death and neonatal morbidity. Raised uterine artery 
Doppler resistance in the third trimester is independently associated with significantly lower 
birthweight and CPR. The combination of the estimated fetal weight, CPR and uterine 
Doppler in the third trimester can identify the majority of fetuses at risk of stillbirth. 
 
 
KEY WORDS: uteroplacental Doppler, fetal Doppler, umbilical artery Doppler, middle 
cerebral artery Doppler, cerberoplacental ratio, fetal growth restriction, term, failure to reach 
growth potential, growth velocity  
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Introduction 
 
Fetal growth restriction (FGR) is a major determinant of stillbirth, perinatal mortality and 
neonatal morbidity, most importantly hypoxic ischemic encephalopathy and cerebral palsy [1-
4]. Despite the fact that two thirds of stillbirths were traditionally considered unexplained, it 
was revealed that 43% of these fetuses were FGR using a different stillbirth post-mortem 
classification system [5]. Furthermore, a retrospective population study has shown that the 
antenatal detection of SGA could potentially halve the risk of stillbirth [6]. Therefore, 
improving the identification of the small for gestational age (SGA) fetuses potentially could 
prevent stillbirth, likely through appropriate antenatal surveillance and timely delivery [6-9]. At 
present, the prenatal detection of SGA is achieved in only about 1 in 4 cases [6-9].  
 
SGA is traditionally defined as birthweight below the 10th centile for gestational age and sex 
according to population references [10,11]. The use of customized centiles adjusts the 
birthweight for maternal height, weight, ethnicity, parity, gestational age, fetal sex, and has 
been shown to classify additional SGA fetuses, which would not have been identified by 
conventional population-based definitions [12]. Studies have demonstrated that those fetuses 
identified as SGA only by customized centiles are at increased risk of adverse outcome, 
while those considered as SGA only by population centiles have similar outcomes to the 
appropriately grown fetsues [12]. However, the concept of customization is controversial at 
present, partially due to the fact that some of the factors which influence fetal size, might not 
have a physiological effect, and that they themselves are known pathological risk factors for 
stillbirth – such as advanced maternal age, increased maternal weight and ethnic origin [13-
15].  
 
The diagnosis of FGR at term is a challenge for clinicians and researchers alike. On the 
other hand, its management is relatively simple – scheduled birth at term is unlikely to result 
in significant short- or long-term harm. Moreover, the long-held belief that induction of labour 
close to term increases the risk of cesarean section has recently been shown in more than 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
4 
 
one study not to be the case. Stock et al. reported that elective induction of labor at term 
reduces perinatal mortality without increasing the risk of operative delivery [16]. This was 
confirmed in a more recent study in which induction of labor at low Bishop scores did not 
increase the risk of cesarean section or poor neonatal outcome [17]. 
 
Estimation of the fetal weight using ultrasound at term also has its limitations. While 
individual fetal parameters can be measured reasonable accurately, the fetal weight is 
estimated by applying one of many formulae to these parameters. Even the best of these 
formulae have a margin of error in the region of +/-15%, and there is evidence that they are 
least accurate in the very small and very large fetuses. Furthermore, until recently there have 
been no standard criteria for the diagnosis of FGR at term. One could argue that the 
diagnosis of FGR is best achieved using longitudinal assessment of fetal biometry. However, 
this ideal is not always feasible as multiple routine scan assessments performed every 3-4 
weeks is required – something that is beyond the scope of resources available in many 
settings. The application of evidence derived from studies of early-onset FGR would be 
inappropriate, as early and late-onset FGR might reflect different pathological processes and 
are known to differ in many aspects [18]. Recently, a consensus definition for late FGR 
(defined as FGR beyond 32 weeks’ gestation) was reached using a Delphi procedure. This 
definition used four parameters: estimated fetal weight (EFW) <10th percentile, abdominal 
circumference (AC) <10th percentile, crossing centiles on growth charts of more than two 
quartiles, and fetal cerebroplacental ratio (CPR) <5th percentile [19]. 
 
FGR is a known risk factor for stillbirth. However, approximately two thirds of the stillbirth 
cases at term have a birthweight more than the 10th centile [20], so relying on the fetal size 
alone will fail to identify a large proportion of fetuses at risk of stillbirth at term. Furthermore, 
recently published data also shows that a fetus loses about 10-30% of its body weight 
between the time of intrauterine demise and subsequent postnatal assessment. The latter 
finding suggests that the majority of stillborn fetuses may have demised whilst still of normal 
weight and only become SGA after demise with the onset of maceration. It is also possible 
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that those stillbirths that result from placental hypoxia represent the tip of the iceberg and 
that for each fetal loss, a greater number of surviving neonates might suffer neurological 
impairment as a result of less severe hypoxia. 
 
 
Assessment of fetal growth at term 
 
For decades, fetal growth has been assessed using ultrasound biometric measurements 
including head circumference (HC), AC and femur length (FL).  It is important to appreciate 
that biometry measured at single ultrasound scan gives information only about fetal size, but 
tells us nothing about fetal nutrition and growth velocity.  Impaired fetal growth velocity, 
defined as a deceleration in the rate of growth measured longitudinally by at least two scans, 
ideally three weeks apart, can be used as a surrogate marker of FGR [21].  Interval growth 
assessment, like any other measurement, is potentially susceptible to inaccuracies as a 
result of intra- and inter-observer variability [22], particularly when the interval between 
examinations is short. 
 
SGA is often used as a proxy for or, sometimes incorrectly, as synonymous with FGR 
[23,24].  However, the majority of SGA fetuses are constitutionally small babies whose 
growth rate is perfectly normal.  Only a proportion of SGA babies have true FGR, i.e. 
suffering a reduction in growth velocity.  Furthermore, it has recently been shown that a 
proportion of appropriate for gestational (AGA) fetuses (that is, fetuses whose EFW lies 
above the 10th centile) also suffer with growth restriction; in other words, despite being a 
good size, their growth velocity is impaired and they are failing to meet their growth potential.  
Indeed the majority of stillbirths at term occur in AGA fetuses [25-27]. A population based 
cohort study using data from the medical birth registry of Norway, which included 1.9 million 
singleton births at or beyond 37 weeks’ gestation, showed that the proportion of stillbirths 
whose weight lies above the 10th centile (i.e. AGA) has been increasing from the 1960s 
(when it was 55%) to the early 2000s (when it was 77%) [27]. 
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Unfortunately, there is no consensus around what constitutes normal or abnormal fetal 
growth velocity.  In clinical practice, serial biometric measures (HC, AC and FL) are plotted 
on a population growth chart.  A fall-off of these measures, especially of the AC, across 
centiles is taken as an indicator of possible FGR. It has been suggested that the use of 
customized growth charts, rather than population growth charts, can potentially reduce the 
risk of stillbirth by using maternal characteristics to adjust centile curves more appropriate to 
the individual fetus [28].  However, the use of customized charts simply shifts the point 
biometric measures from one centile to another (and so could potentially shift a fetus from 
AGA to SGA or vice versa), but in itself does not alter the growth velocity.  In other words, it 
can potentially alert the clinician to the fact that a baby is small (according to its customized 
centile chart) and so trigger more close monitoring, but does not indicate whether the fetus is 
growth restricted any better than when population growth charts are used. 
 
It has long been recognized that impaired fetal growth is associated with adverse pregnancy 
outcomes.  De Jong showed in 1999 that the fetal growth rate was significantly lower in 
pregnancies that had operative delivery for presumed fetal distress (20.9 g/day) or neonatal 
unit admission (20.3 g/day) compared to those with uncomplicated outcome (21.9 g/day) 
[29].  A large screening study of 4,512 nulliparous woman recruited over a four year period in 
Cambridge UK [30] found that an EFW below the 10th centile was associated with an 
increased risk of neonatal morbidity, but only if the fetal AC growth velocity was in the lowest 
decile (relative risk of 17.6).  In 2008, Eixarch showed that only fetuses with signs of cerebral 
redistribution, identified as those with a low middle cerebral artery (MCA) pulsatility index 
(PI), suffered from lower communication and problem solving scores in childhood [31].  
Interestingly, term SGA fetuses with normal MCA PI had similar neurodevelopmental 
outcomes to those above the 10th centile with normal MCA PI.  All of this evidence supports 
the concept that it is impaired fetal growth velocity, rather than size per se, that puts a fetus 
at risk of adverse outcome. 
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It is notable that the improvement of the detection of SGA neonates using assessment of the 
fetal growth (biometry) was associated with a high false positive rate (two false positives for 
each additional SGA neonate detected), as shown in the Cambridge screening study [30].  It 
is clear, therefore, that additional parameters such as fetal Doppler or biochemical markers, 
such as placental growth factor, are required to optimize the identification of fetuses at risk of 
adverse outcome [30,32]. 
 
Uterine artery Doppler 
 
Conventionally, uterine artery Doppler indices have been measured in the second trimester 
when increased resistance has been taken as an indicator of impaired trophoblastic invasion 
of the maternal spiral arteries, and associated with an increased risk of later pregnancy 
complications due to placental dysfunction, such as preeclampsia, SGA and FGR [33-35]. It 
has also been demonstrated that uterine artery Doppler indices at the end of the first 
trimester may also predict preeclampsia, FGR, placental abruption and stillbirth, although 
with less sensitivity and specificity than second trimester measures [33-39]. More recently, 
longitudinal studies have reported progressive deterioration of uterine artery Doppler indices 
in women who go on to develop preeclampsia [34].  This has led to a shift in emphasis from 
a single point assessment to monitoring the longitudinal trend. 
 
Recently it has been shown that uterine artery Doppler indices in the third trimester might be 
of clinical value [40-44].  Some studies have suggested that the predictive value of third 
trimester uterine artery Doppler is comparable to that of umbilical artery Doppler when 
predicting adverse pregnancy outcomes in late onset FGR [45-47]. More recent findings 
suggest that third trimester uterine artery Doppler was significantly associated with the risk of 
stillbirth and perinatal death [48]. Raised uterine artery mean PI in the third trimester is 
associated with significantly lower birthweight and fetal CPR.  Indeed, uterine artery Doppler 
in the third trimester is an independent predictor of the fetal CPR, even after adjusting for 
birthweight centile or SGA. 
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Fetal Doppler 
 
Although it is now well established that fetal Doppler is a valuable tool in the assessment and 
management of high-risk pregnancies, this is not the case with regard to low risk 
pregnancies where the evidence of its benefit is lacking.  Growth restricted fetuses are 
characterized by an increase in the resistance to flow in the umbilical artery (increased PI) 
and may develop a reduction in the MCA PI.  This latter finding is an indication of brain 
sparing in which available oxygen and nutrition is redistributed towards the vital organs 
(brain, heart and adrenal glands) and away from those less critical organs.  These two 
Doppler findings (increased umbilical artery PI and reduced MCA PI) can be combined in 
CPR, which is the simple ratio between the MCA PI and the umbilical artery PI. In FGR, as 
the umbilical artery Pi is increased, and the MCA PI may be reduced, the CPR is low.  
 
Fetal brain sparing (low MCA PI or CPR) has been associated with adverse pregnancy 
outcomes, even in fetuses with normal umbilical artery Doppler [45,49].  However, the CPR 
improves the prediction of adverse pregnancy outcomes when compared to its individual 
components [49-53].  It has been shown that a suboptimal or low CPR is associated with 
short-term markers of neonatal outcome such as cord blood acidemia, need for emergency 
operative delivery and neonatal unit admission [54-57], as well as stillbirth and neonatal 
morbidity [48, 57-59]. 
 
Fetuses with late onset FGR, in particular those with abnormal MCA Doppler, were found to 
have a significantly smaller corpus callosum at term than AGA fetuses [60]; this in turn was 
associated with an increased risk of neurobehavioral disorders in FGR babies. The same 
group showed that SGA fetuses with cerebral blood flow redistribution have a higher 
incidence of neurodevelopmental deficit at the age of two years, achieving a lower mean 
centile in communication and problem solving [31].  Furthermore, small fetuses with 
abnormal CPR were more likely to suffer with a deficit in cognitive functioning and academic 
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achievement in all domains at the age of six to eight years [61].  In this study, abnormal CPR 
predicted low academic scores in children born at term [61]. 
 
In common with studies of individual Doppler parameters, the majority of studies of CPR 
have until recently focused on SGA fetuses.  In a recent meta-analysis, abnormal CPR in 
SGA fetuses was associated with an increased risk of cesarean section for presumed fetal 
distress (OR 7.4; 95% CI 2.5 to 21.5), low 5-minute Apgar score (OR 6.9; 95% CI 0.96 to 
49.1), neonatal unit admission (OR 13.0; 95% CI 6.0 to 27.9) and neonatal complications 
(OR 20.4; 95% CI 8.7 to 47.6) [62].  The equivalent sensitivities for each of these outcomes 
were 44-70%, 50-80%, 40-81%, and 39-86%, respectively.  The corresponding specificities 
were 56-93%, 54-80%, 53-96%, and 53-97%, respectively [62].  Furthermore, the findings of 
the PORTO study reinforced the importance of CPR in identifying at risk fetuses; FGR 
fetuses with abnormal CPR had a 11-fold increase in the risk of adverse pregnancy 
outcomes, in particular neonatal morbidity, when compared to those with normal CPR [59]. 
 
We recently reported that the CPR is a marker of failure to reach growth potential and 
adverse pregnancy outcomes, in both AGA and SGA fetuses [55,56], and this has been 
discussed in a recent review [63].  Most studies that assessed the utility of CPR in identifying 
at risk fetuses used point estimates and lacked longitudinal data. Given that fetuses 
considered to be at risk, such as those diagnosed to be SGA, are monitored with serial 
ultrasound examinations, it should be possible, and indeed would be preferable, to use 
reference ranges for CPR based on studies with a longitudinal design [64].  However, the 
reference ranges currently used for CPR are based on cross sectional studies and thus more 
suitable for single observations rather than serial monitoring [63-68]. 
 
CPR is lower in fetuses suffering with FGR that are therefore at increased risk of stillbirth 
[48].  However, in normal fetuses, CPR normally falls after  
34 weeks of gestation [66,69].  It is conceivable that the rate and/or magnitude of this fall 
might be greater in at risk fetuses.  In a recent study, the conditional centile for CPR ≤5th and 
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≤10th was associated with adverse perinatal outcomes [70].  Moreover, adding the 
conditional centile to the conventional centile for CPR has improved the prediction of adverse 
perinatal outcomes, compared to the use of the conventional centile alone [70].  The adverse 
perinatal outcomes described in this study included preterm birth, operative delivery for fetal 
distress, neonatal unit admission, 5-minute Apgar score less than 7, neonatal hypoglycemia 
and perinatal mortality.  It remains to be established whether a steeper than expected fall in 
the CPR can predict fetal demise. 
 
A model of fetal surveillance 
 
Until recently, it is primarily SGA fetuses that have been considered at risk of adverse 
outcomes and therefore subjected to increased surveillance, using both biometric and 
Doppler measurements.  Similarly, the focus of most research on FGR has been on SGA 
fetuses; indeed, many publications have erroneously used the terms SGA and FGR as if they 
were interchangeable. However, the weight of evidence is increasing that a large proportion 
of SGA fetuses are not growth restricted, while a significant proportion of AGA fetuses are 
growth restricted and therefore at increased risk of adverse outcome, including stillbirth.  
There is a rise in the incidence of stillbirth and perinatal mortality with reducing birthweight 
centiles, even in those with birthweight centile above the 80th [26,71,72]. This fact is 
consistent with our recent observation of increasing the proportion of low CPR with reducing 
birthweight centiles, even in those above the 10th centile (Figure 1) [73].  
 
We have therefore suggested a combined assessment approach for adverse outcomes, 
using both fetal biometry and CPR [73] (Figure 2). The model combines the data based on 
the assessment of the fetal biometry, which is the conventional model using the 10th centile 
of EFW as the cut-off to identify those fetuses at risk of adverse outcome, and 
hemodynamics. We applied a threshold of the 5th centile of CPR from the group of fetuses 
least likely to suffer from the consequences of growth restriction (77th-90th centile of 
birthweight). Accordingly, regardless of fetal weight centile, we proposed that fetuses with 
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CPR MoM values below this cut-off are considered at increased risk of adverse pregnancy 
outcomes secondary to late-onset placental insufficiency or insult [73] (Figure 1). 
Interestingly, AGA fetuses with abnormal CPR were more prone to poor acid-base status at 
birth compared to those with normal CPR [54]. 
 
For both biometry and CPR, the rate of change is likely to be of greater value than point 
estimates.  Such an approach is likely to optimize the identification of fetuses that are failing 
to reach their individual growth potential [58], regardless of whether their estimated weight is 
above or below the 10th centile.  We recently showed that CPR combined with uterine artery 
Doppler and EFW in the third trimester could identify the majority of pregnancies complicated 
by stillbirth and perinatal loss [48]. This is the primary goal of identifying FGR at term; once 
identified, management is easy by early delivery. 
 
Conclusion 
 
It is increasingly clear that the use of point estimates of biometry is inadequate for assessing 
fetuses for growth restriction at term and identifying those at increased risk of adverse 
perinatal outcome.  Serial measurements to assess growth velocity, combined with Doppler 
measures to identify those fetuses with redistribution, are preferable.  The CPR, a measure 
combining both umbilical and MCA Doppler indices, appears to be a very promising tool for 
optimizing the identification of at risk fetuses.  It is clear that prospective studies are needed 
to identify the best markers for the diagnosis of subtle hypoxia at term, the potential for 
neurological damage in AGA fetuses with abnormal CPR, and the optimal timing for 
screening for adverse outcomes in the third trimester. 
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PRACTICE POINTS 
 Fetal growth restriction is a major determinant of stillbirth, perinatal mortality and neonatal 
morbidity  
 The majority of fetuses suffering from stillbirth at term are not small for gestational age 
 The cerebroplacental ratio (CPR) is emerging as a marker of failure to reach growth 
potential at term 
 The combination of the estimated fetal weight, CPR and uterine Doppler in the third 
trimester can identify the majority of fetuses at risk of stillbirth 
 
RESEARCH AGENDA 
 Diagnostic markers of hypoxia and potential neurological damage at term 
 The potential value of the cerebroplacental ratio (CPR), in combination with other 
biophysical and biochemical markers, in identifying the fetuses at risk of adverse 
outcome at term 
 Optimal timing for screening for adverse outcomes at term 
 
SUMMARY 
Despite the fact that fetal growth restriction (FGR) is a known risk factor for stillbirth, the 
majority of fetuses suffering from stillbirth at term are not small for gestational age. It is 
increasingly clear that the use of point estimates of biometry are inadequate for assessing 
FGR at term and identifying those at increased risk of adverse perinatal outcome.  Serial 
measurements to assess growth velocity, combined with Doppler measures to identify those 
fetuses with redistribution, are preferable.  The cerebroplacental ratio (CPR), a measure 
combining both umbilical and MCA Doppler indices, is emerging as a marker of failure to 
reach growth potential at term and could help identifying the at risk fetuses.  The combination 
of the estimated fetal weight, CPR and uterine Doppler in the third trimester can identify the 
majority of fetuses at risk of stillbirth or perinatal death. It is clear that prospective studies are 
needed to identify the best markers for the diagnosis of hypoxia at term and the optimal 
timing for screening for adverse outcomes in the third trimester. 
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Figures legend 
 
Figure 1. The proportion of term fetuses with failure to reach growth potential (FRGP) 
according to their birthweight (BW) centile group (i.e. proportion of fetuses with a 
cerebroplacental ratio (CPR) multiple of the median (MoM) value below the established 
FRGP normality threshold (CPR MoM=0.6765), which was calculated after subtracting those 
cases with CPR MoM below the 5th centile observed in the group with BW >90th centile). 
Appropriate-for-gestational-age (AGA) fetuses show a progressive decrease of CPR, which 
is especially important in the group with BW<25th centile. *Chi-square test plus Holms’s 
correction for multiple comparisons. 
 
This figure corresponds to reference [73] 
 
Figure 2. Scattergram showing the combined model for the screening of adverse outcome in 
late fetal growth restriction, according to cerebroplacental ratio multiples of the median (CPR 
MoM) and birthweight centile. Group 1, small-for-gestational-age (SGA) fetuses with 
abnormal CPR; Group 2, appropriate-for-gestational-age (AGA) and large-for-gestational-age 
(LGA) fetuses with abnormal CPR; Group 3, SGA fetuses with normal CPR; Group 4, AGA 
and LGA fetuses with normal CPR. Our proposal includes identifies group 3 as fetuses with 
potential adverse outcome. These fetuses were earlier considered as normal fetuses. 
 
This figure corresponds to reference [73] 
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